ID   CD8A_RAT                Reviewed;         236 AA.
AC   P07725;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   29-MAY-2024, entry version 173.
DE   RecName: Full=T-cell surface glycoprotein CD8 alpha chain;
DE   AltName: Full=CD8 antigen 32 kDa chain;
DE   AltName: Full=OX-8 membrane antigen;
DE   AltName: CD_antigen=CD8a;
DE   Flags: Precursor;
GN   Name=Cd8a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3932064; DOI=10.1002/j.1460-2075.1985.tb03968.x;
RA   Johnson P., Gagnon J., Barclay A.N., Williams A.F.;
RT   "Purification, chain separation and sequence of the MRC OX-8 antigen, a
RT   marker of rat cytotoxic T lymphocytes.";
RL   EMBO J. 4:2539-2545(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   GLYCOSYLATION AT ASN-63; THR-144; THR-148; THR-152; THR-158 AND THR-160.
RX   PubMed=1908233; DOI=10.1016/0006-291x(91)91019-9;
RA   Gooley A.A., Classon B.J., Marschalek R., Williams K.L.;
RT   "Glycosylation sites identified by detection of glycosylated amino acids
RT   released from Edman degradation: the identification of Xaa-Pro-Xaa-Xaa as a
RT   motif for Thr-O-glycosylation.";
RL   Biochem. Biophys. Res. Commun. 178:1194-1200(1991).
CC   -!- FUNCTION: Integral membrane glycoprotein that plays an essential role
CC       in the immune response and serves multiple functions in responses
CC       against both external and internal offenses. In T-cells, functions
CC       primarily as a coreceptor for MHC class I molecule:peptide complex. The
CC       antigens presented by class I peptides are derived from cytosolic
CC       proteins while class II derived from extracellular proteins. Interacts
CC       simultaneously with the T-cell receptor (TCR) and the MHC class I
CC       proteins presented by antigen presenting cells (APCs). In turn,
CC       recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. LCK
CC       then initiates different intracellular signaling pathways by
CC       phosphorylating various substrates ultimately leading to lymphokine
CC       production, motility, adhesion and activation of cytotoxic T-
CC       lymphocytes (CTLs). This mechanism enables CTLs to recognize and
CC       eliminate infected cells and tumor cells. In NK-cells, the presence of
CC       CD8A homodimers at the cell surface provides a survival mechanism
CC       allowing conjugation and lysis of multiple target cells. CD8A homodimer
CC       molecules also promote the survival and differentiation of activated
CC       lymphocytes into memory CD8 T-cells. {ECO:0000250|UniProtKB:P01732}.
CC   -!- SUBUNIT: Forms disulfide-linked heterodimers with CD8B at the cell
CC       surface. Forms also homodimers in several cell types including NK-cells
CC       or peripheral blood T-lymphocytes. Interacts with the MHC class I HLA-
CC       A/B2M dimer. Interacts with LCK in a zinc-dependent manner.
CC       {ECO:0000250|UniProtKB:P01732}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P01732};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P01732}.
CC       Note=CD8A localizes to lipid rafts only when associated with its
CC       partner CD8B. {ECO:0000250|UniProtKB:P01732}.
CC   -!- PTM: Palmitoylated, but association with CD8B seems to be more
CC       important for the enrichment of CD8A in lipid rafts.
CC       {ECO:0000250|UniProtKB:P01732}.
CC   -!- PTM: O-glycosylated. {ECO:0000250|UniProtKB:P01732}.
CC   -!- PTM: Phosphorylated in cytotoxic T-lymphocytes (CTLs) following
CC       activation. {ECO:0000250|UniProtKB:P01732}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X03015; CAA26798.1; -; mRNA.
DR   EMBL; BC088126; AAH88126.1; -; mRNA.
DR   PIR; A24637; A24637.
DR   RefSeq; NP_113726.1; NM_031538.2.
DR   RefSeq; XP_006236692.1; XM_006236630.3.
DR   RefSeq; XP_008761198.1; XM_008762976.2.
DR   AlphaFoldDB; P07725; -.
DR   SMR; P07725; -.
DR   DIP; DIP-60779N; -.
DR   IntAct; P07725; 1.
DR   STRING; 10116.ENSRNOP00000009516; -.
DR   GlyCosmos; P07725; 6 sites, No reported glycans.
DR   GlyGen; P07725; 6 sites.
DR   iPTMnet; P07725; -.
DR   PhosphoSitePlus; P07725; -.
DR   PaxDb; 10116-ENSRNOP00000009516; -.
DR   Ensembl; ENSRNOT00000009515.5; ENSRNOP00000009516.3; ENSRNOG00000007178.5.
DR   Ensembl; ENSRNOT00055034849; ENSRNOP00055028264; ENSRNOG00055020405.
DR   Ensembl; ENSRNOT00060025082; ENSRNOP00060019979; ENSRNOG00060014674.
DR   Ensembl; ENSRNOT00065007608; ENSRNOP00065005274; ENSRNOG00065005181.
DR   GeneID; 24930; -.
DR   KEGG; rno:24930; -.
DR   UCSC; RGD:2316; rat.
DR   AGR; RGD:2316; -.
DR   CTD; 925; -.
DR   RGD; 2316; Cd8a.
DR   eggNOG; ENOG502SAZN; Eukaryota.
DR   GeneTree; ENSGT00940000156588; -.
DR   HOGENOM; CLU_085753_0_0_1; -.
DR   InParanoid; P07725; -.
DR   OMA; FRMSPTQ; -.
DR   OrthoDB; 5323965at2759; -.
DR   PhylomeDB; P07725; -.
DR   TreeFam; TF336070; -.
DR   Reactome; R-RNO-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   PRO; PR:P07725; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000007178; Expressed in thymus and 17 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0044853; C:plasma membrane raft; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0023024; F:MHC class I protein complex binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:0045065; P:cytotoxic T cell differentiation; ISO:RGD.
DR   GO; GO:0051607; P:defense response to virus; ISO:RGD.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0042110; P:T cell activation; ISO:RGD.
DR   GO; GO:0002456; P:T cell mediated immunity; ISO:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:RGD.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR015468; CD8_asu.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   PANTHER; PTHR10441; CD8 ALPHA CHAIN; 1.
DR   PANTHER; PTHR10441:SF2; T-CELL SURFACE GLYCOPROTEIN CD8 ALPHA CHAIN; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Cell membrane; Disulfide bond; Glycoprotein; Immunity;
KW   Immunoglobulin domain; Lipoprotein; Membrane; Palmitate;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..236
FT                   /note="T-cell surface glycoprotein CD8 alpha chain"
FT                   /id="PRO_0000014641"
FT   TOPO_DOM        27..189
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        190..210
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        211..236
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          27..130
FT                   /note="Ig-like V-type"
FT   REGION          150..170
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        150..164
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           211
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P01732"
FT   CARBOHYD        63
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:1908233"
FT   CARBOHYD        144
FT                   /note="O-linked (GalNAc...) threonine; partial"
FT                   /evidence="ECO:0000269|PubMed:1908233"
FT   CARBOHYD        148
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:1908233"
FT   CARBOHYD        152
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:1908233"
FT   CARBOHYD        158
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:1908233"
FT   CARBOHYD        160
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:1908233"
FT   DISULFID        47..119
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   236 AA;  26196 MW;  ADFAC54E4C99C1BE CRC64;
     MASRVICFLS LNLLLLDVIT RLQVSGQLQL SPKKVDAEIG QEVKLTCEVL RDTSQGCSWL
     FRNSSSELLQ PTFIIYVSSS RSKLNDILDP NLFSARKENN KYILTLSKFS TKNQGYYFCS
     ITSNSVMYFS PLVPVFQKVN SIITKPVTRA PTPVPPPTGT PRPLRPEACR PGASGSVEGM
     GLGFACDIYI WAPLAGICAV LLLSLVITLI CCHRNRRRVC KCPRPLVKPR PSEKFV
//
